Table 2.

Comparing the s-CSF2-Ab and s-CSF2pep-Ab levels between HDs and patients with AMI or DM.

Sample information		HD	AMI	DM
Total sample number		128	128	128
Male/Female		72/56	105/23	72/56
Age (Average ± SD)		58.29 ± 5.63	58.20 ± 8.50	58.48 ± 9.17
		s-CSF2-Ab	s-CSF2pep-Ab
HD	Average	27,010	3,006
	SD	19,725	2,234
	Cutoff values	66,460	7,474
	Total number	128	128
	Positive number	3	2
	Positive (%)	2.3%	1.6%
AMI	Average	37,075	4,979
	SD	22,495	2,503
	Total number	128	128
	Positive number	13	15
	Positive (%)	10.2%	11.7%
	P value (vs HD)	<0.0001	<0.0001
DM	Average	40,329	4,851
	SD	36,680	4,096
	Total number	128	128
	Positive number	17	13
	Positive (%)	13.3%	10.2%
	P value (vs HD)	<0.0001	<0.0001

The upper panel indicates the number of total samples, samples from male and female participants, and ages (average ± SD). The lower panel summarizes the s-CSF2-Ab and s-CSF2pep-Ab levels examined using AlphaLISA. Numbers are as shown in Table 1; P values of <0.05 and positive rates of >10% are marked in bold font. The plots for these data are shown in Figures 3A,B. AMI, acute myocardial infarction; DM, diabetes mellitus.